Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
179.87
+0.25 (0.14%)
Dec 10, 2025, 12:47 PM EST - Market open
Quest Diagnostics Revenue
Quest Diagnostics had revenue of $2.82B in the quarter ending September 30, 2025, with 13.18% growth. This brings the company's revenue in the last twelve months to $10.85B, up 13.74% year-over-year. In the year 2024, Quest Diagnostics had annual revenue of $9.87B with 6.70% growth.
Revenue (ttm)
$10.85B
Revenue Growth
+13.74%
P/S Ratio
1.85
Revenue / Employee
$193,750
Employees
56,000
Market Cap
20.01B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.87B | 620.00M | 6.70% |
| Dec 31, 2023 | 9.25B | -631.00M | -6.38% |
| Dec 31, 2022 | 9.88B | -905.00M | -8.39% |
| Dec 31, 2021 | 10.79B | 1.35B | 14.32% |
| Dec 31, 2020 | 9.44B | 1.71B | 22.15% |
| Dec 31, 2019 | 7.73B | 195.00M | 2.59% |
| Dec 31, 2018 | 7.53B | 129.00M | 1.74% |
| Dec 31, 2017 | 7.40B | 188.00M | 2.61% |
| Dec 31, 2016 | 7.21B | -279.00M | -3.72% |
| Dec 31, 2015 | 7.49B | 58.00M | 0.78% |
| Dec 31, 2014 | 7.44B | 289.00M | 4.04% |
| Dec 31, 2013 | 7.15B | -237.00M | -3.21% |
| Dec 31, 2012 | 7.38B | -9.00M | -0.12% |
| Dec 31, 2011 | 7.39B | 131.88M | 1.82% |
| Dec 31, 2010 | 7.26B | -195.12M | -2.62% |
| Dec 31, 2009 | 7.46B | 205.80M | 2.84% |
| Dec 31, 2008 | 7.25B | 544.54M | 8.12% |
| Dec 31, 2007 | 6.70B | 436.25M | 6.96% |
| Dec 31, 2006 | 6.27B | 811.93M | 14.88% |
| Dec 31, 2005 | 5.46B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
DGX News
- 1 day ago - Digi Power X Inc. (DGX:CA) Presents at IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 Transcript - Seeking Alpha
- 7 days ago - Quest Diagnostics Incorporated (DGX) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 9 days ago - Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave® Multiple Sclerosis Disease Activity (MSDA) Test Across the United States - Business Wire
- 25 days ago - Quest Diagnostics Incorporated (DGX) Presents at 7th Annual Healthcare Symposium Transcript - Seeking Alpha
- 26 days ago - Digi Power X Inc. (DGX:CA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Daily Dividend Report: ADP, Agree Realty, Group 1, DGX, Aflac - Forbes
- 4 weeks ago - Quest Diagnostics Declares Quarterly Cash Dividend - PRNewsWire
- 5 weeks ago - Quest Diagnostics to Speak at Citi's 2025 Global Healthcare Conference - PRNewsWire